With Coronavirus Vaccines Still In Development, These 3 Stocks Are Poised To Soar This Year (With Some Risk)

In 2021, “The big stories…could come from vaccines that haven’t made it to market yet. It’s possible that the stocks of the companies developing these experimental vaccines will deliver tremendous gains over the next 12 months,” advises the author of today’s article. With that, he proceeds to highlight three coronavirus vaccine stocks that, while risky, appear especially well positioned to soar this year. For these three stocks, CLICK HERE.